1-8 of 8
David Reiser
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Spliceosome Mutations Are Common in MPN-Associated Myelofibrosis with RBC-Transfusion-Dependence and Correlate with Response to Pomalidomide

Onima Chowdhury, MD PhD, Jennifer O'Sullivan, MB BCh BAO, Nikolas Barkas, Gemma Buck, BSc, Angela Hamblin, MD PhD, Ayalew Tefferi, MD, Haifa Al-Ali, Giovanni Barosi, MD, Timothy Devos, Heinz Gisslinger, Qian Jiang, MD, Jean-Jacques Kiladjian, MD PhD, Ruben A. Mesa, MD FACP, Francesco Passamonti, MD, Vincent Ribrag, MD, Gary J. Schiller, MD, Alessandro M. Vannucchi, MD, Daobin Zhou, MD, Mary Frances McMullin, MD, David Reiser, Jim Zhong, Robert Peter Gale, Adam J. Mead, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3037.
https://doi.org/10.1182/blood-2018-99-119402
Published: 2018
Journal Articles

Vorinostat Combined with Bortezomib In Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Update on the Vantage Study Program

David S Siegel, MD, PhD, Sundar Jagannath, MD, Roman Hajek, MD, PhD, Meletios A. Dimopoulos, MD, Sung-Soo Yoon, MD, PhD, Sagar Lonial, MD, Jacob P. Laubach, MD, MPP, Thorsten Graef, MD, PhD, Dina Pietrangelo, Lisa Lupinacci, David Reiser, Kenneth C. Anderson, MD
Journal: Blood
Blood (2010) 116 (21): 1952.
https://doi.org/10.1182/blood.V116.21.1952.1952
Published: 2010
Journal Articles

The Combination of Vorinostat and Bortezomib Provides Long-Term Responses in Patients with Relapsed or Refractory Multiple Myeloma.

Sundar Jagannath, MD, Donna Weber, MD, Ronald Sobecks, Gary J Schiller, Lisa Lupinacci, David Reiser, Judith Allen, Syed Rizvi
Journal: Blood
Blood (2009) 114 (22): 3886.
https://doi.org/10.1182/blood.V114.22.3886.3886
Published: 2009
Journal Articles

Update On the Phase IIb, Open-Label Study of Vorinostat in Combination with Bortezomib in Patients with Relapsed and Refractory Multiple Myeloma.

David Siegel, Sundar Jagannath, MD, Sagar Lonial, MD, Meletios A. Dimopoulos, Thorsten Graef, MD, PhD, Dina Pietrangelo, Lisa Lupinacci, David Reiser, Syed Rizvi, Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 3890.
https://doi.org/10.1182/blood.V114.22.3890.3890
Published: 2009
Journal Articles

Combined Vorinostat, Lenalidomide and Dexamethasone Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Phase I Study.

David Siegel, Donna M Weber, MD, Constantine S. Mitsiades, Meletios A. Dimopoulos, Jean-Luc Harousseau, Syed Rizvi, Jason Howe, David Reiser, Catriona Byrne, Kenneth C. Anderson, MD, Paul Richardson, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 305.
https://doi.org/10.1182/blood.V114.22.305.305
Published: 2009
Journal Articles

Vorinostat Plus Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma: Early Clinical Experience

Donna Weber, Ashraf Z. Badros, Sundar Jagannath, David Siegel, Victoria Richon, Syed Rizvi, Jose Garcia-Vargas, David Reiser, Kenneth C. Anderson
Journal: Blood
Blood (2008) 112 (11): 871.
https://doi.org/10.1182/blood.V112.11.871.871
Published: 2008
Journal Articles

A Phase I Study of Vorinostat in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

David Siegel, Donna Weber, MD, Constantine S. Mitsiades, MD, PhD, Syed Rizvi, Jose Garcia-Vargas, Jason Howe, David Reiser, Kenneth C. Anderson, MD, Paul Richardson, MD
Journal: Blood
Blood (2008) 112 (11): 3705.
https://doi.org/10.1182/blood.V112.11.3705.3705
Published: 2008
Journal Articles

Combination of Vorinostat Plus Bortezomib for the Treatment of Patients with Multiple Myeloma Who Have Previously Received Bortezomib

Donna M. Weber, Sundar Jagannath, MD, Ronald Sobecks, Gary Schiller, Lisa Chiacchierini, David Reiser, Carol Oerth, Jose Garcia-Vargas, Syed Rizvi
Journal: Blood
Blood (2008) 112 (11): 3711.
https://doi.org/10.1182/blood.V112.11.3711.3711
Published: 2008